Clinical Trial Update: The IMAP Study Improving Management of Mildly Abnormal Pap Smears [Phase 3]

View source ↗

Summary

An update on the Phase 3 IMAP trial evaluating management strategies for mildly abnormal Pap smears.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Neoplasms

Snippet

Sponsor: University of Sydney | Conditions: Cervix Neoplasms | Phase 3 | Status: UNKNOWN